
Recognition reinforces the growing consumer relevance of IQOS and the strength of Philip Morris International&#39;s smoke-free vision


Philip Morris International&#39;s (PMI) (NYSE:PM) IQOS, the #1 tobacco heating system1, has

Recognition reinforces the growing consumer relevance of IQOS and the strength of Philip Morris International's smoke-free vision


Philip Morris International's (PMI) (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/PM">PM</a>) IQOS, the #1 tobacco heating system1, has been listed for the first time as one of the top 100 most valuable brands in the world in <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://www.kantar.com/" shape="rect">Kantar's</a> BrandZ 2026 Most Valuable Global Brands. This ranking solidifies IQOS's global momentum and its emergence as a culturally relevant, iconic brand for adult nicotine users seeking better alternatives to cigarettes.


According to the BrandZ 2026 Most Valuable Global Brands, IQOS achieved a ranking of #74 globally.


With more than 35 million IQOS users worldwide—most of whom have fully switched away from cigarettes2—the brand continues to lead from the front and champion in a smoke-free era through science-backed innovation and consumer-centric design. Within 10 years of inception, IQOS surpassed $10 billion in annual net revenues, reaching this milestone faster than some of the world's most recognized technology companies—and making up the large majority of Philip Morris International's smoke-free business which reached close to $17 billion in net revenues in 2025.


"This milestone is a powerful validation of the journey we are on," said Oggie Kapetanovic, President Heat-Not-Burn Products at Philip Morris International. "IQOS is not only the world's leading smoke-free brand - it is becoming a truly iconic brand, built on science, innovation, and consumer trust. This recognition reaffirms IQOS's continued growth and its pivotal role in transforming the industry. It inspires us to go further, faster, in delivering better alternatives for adults who would otherwise smoke."


BrandZ charts the way in which global brands have continued to evolve and innovate. Now in its 21st edition, it spotlights the importance of building meaningful difference where a brand meets consumer needs, stands out from competitors and remains top-of-mind in its sector for a prolonged period.


"The brand era has changed. People now interact with brands in thousands of different ways. Many of these are shaped by AI, like personalized feeds or LLMs that influence what we see. Machines are increasingly surfacing and prioritizing content. That means brands need to work harder than ever to stand out as meaningful and different," said Martin Guerrieria, Head of Kantar BrandZ.


IQOS's inclusion in the Kantar Top 100 for the first time underscores its growing role beyond product innovation — positioning the brand at the intersection of technology, design, and culture, aiming to meet the preferences of adult nicotine users. This recognition marks another important step toward achieving a future where cigarettes can become obsolete.


Other notable brands featured in this year's BrandZ 2026 global rankings include Google, Claude and Chinese-based companies like Alibaba and Xiaomi, highlighting industry leaders driving global brand value. Kantar BrandZ is a global ranking that assesses brand value by combining financial data and extensive brand equity research, offering an in-depth view of over 22,000 brands in 54 markets.


IQOS is not risk-free and provides nicotine, which is addictive. Only for use by adults who would otherwise smoke or use nicotine products.

<table xmlns="http://www.w3.org/1999/xhtml" cellspacing="0" class="bwtablemarginb bwblockalignl">
<tr xmlns="http://www.w3.org/1999/xhtml">
<td xmlns="http://www.w3.org/1999/xhtml" class="bwvertalignt bwpadl0" rowspan="1" colspan="1">
1 PMI global estimates of total in Market Sales of Heated Tobacco Units as of December 2025



</td>

</tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<td xmlns="http://www.w3.org/1999/xhtml" class="bwvertalignt bwpadl0" rowspan="1" colspan="1">
2 Source: PMI Q4 2025 Earnings Release



</td>

</tr>
</table>
Philip Morris International: A Global Smoke-Free Champion


Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 43% of PMI's first-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to "PMI", "we", "our" and "us" mean Philip Morris International Inc., and its subsidiaries. For more information, please visit <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.pmi.com/" shape="rect">www.pmi.com</a> and <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.pmiscience.com/" shape="rect">www.pmiscience.com</a>.


Forward-Looking and Cautionary Statements


This press release contains projections of future results and goals and other forward-looking statements, including statements regarding business plans and strategies. Achievement of future results is subject to risks, uncertainties, and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.


PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco and/or nicotine use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of natural disasters and pandemics on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products' performance.


PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2024 and the Quarterly Report on Form 10-Q for the second quarter ended June 30, 2025. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.


About Kantar


Kantar is the world's leading marketing data and analytics business. We deliver the intelligence needed to power brand growth.


We provide the signals that help organizations act quickly and confidently. We empower brands to make effective marketing decisions based on predictive evidence. And we help them craft powerful growth strategies rooted in the connection between consumers, brands and enterprise value. All this is powered by our uniquely robust human and synthetic data, our unrivalled IP, our AI-native platform and the team of global brand experts that bring this all together.


About Kantar BrandZ


Kantar BrandZ is the global currency when assessing brand value, quantifying the contribution of brands to business' financial performance. Kantar's annual global and local brand valuation rankings combine rigorously analyzed financial data, with extensive brand equity research. Since 1998, BrandZ has shared brand-building insights with business leaders based on interviews with 4.6 million consumers, for over 22,000 brands in 54 markets. Discover more about Kantar BrandZ <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://www.kantar.com/campaigns/brandz" shape="rect">here</a>.

<img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260526629537r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260526629537/en/" rel="nofollow">https://www.businesswire.com/news/home/20260526629537/en/</a>
Corey Henry
 Philip Morris International
 T: +1 (202) 679 7296
 E: <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:corey.henry@pmi.com" shape="rect">corey.henry@pmi.com</a>

IQOS One of the Most Valuable Global Brands, According to Kantar's BrandZ 2026 Ranking

BrandZ Ranking Elevates PMI IQOS as Global Smoke-Free Leader

<section class="insight" data-version="1">
 <section data-block="information">
 <h3>Information</h3>
 Recognition reinforces the growing consumer relevance of IQOS and the strength of Philip Morris International&amp;#39;s smoke-free vision


Philip Morris International&amp;#39;s (PMI) (NYSE:PM) IQOS, the #1 tobacco heating system1, has
 </section>

 <section data-block="ai-summary-paragraph">
 <h3>AI Summary</h3>
 Philip Morris International&#039;s IQOS has been recognized in BrandZ&#039;s 2026 Top 100 global brands, ranking #74 and underscoring strong momentum in smoke-free products. PMI notes over 35 million IQOS users and that the smoke-free segment comprised about 43% of Q1 2026 net revenues, with 2025 smoke-free net revenues near $17B. FDA MRTP approvals further validate the platform and could bolster growth and brand credibility.
 </section>

 <section data-block="ai-summary-bullets">
 <h3>Key Points</h3>
 <ul><li>IQOS named in BrandZ 2026 Top 100 globally (#74).</li><li>35+ million IQOS users; 2025 smoke-free net revenues near $17B.</li><li>Smoke-free business accounted for 43% of PMI&#039;s Q1 2026 net revenues.</li><li>FDA MRTPs support IQOS devices and ZYN nicotine pouches; Broadens approvals.</li></ul>
 </section>

 <section data-block="companies-mentioned">
 <h3>Companies Mentioned</h3>
 <ul><li>Philip Morris International (PM): PMI’s IQOS is central to its smoke-free strategy; BrandZ validation supports growth narrative.</li><li>IQOS (N/A): PMI&#039;s flagship smoke-free device; key revenue and branding driver; not a separate traded name.</li><li>Kantar BrandZ (N/A): Brand valuation methodology underpinning the ranking; strengthens PMI branding context.</li></ul>
 </section>

 <section data-block="category">
 <h3>Industry News</h3>
 Industry News – Branding and regulatory milestones shaping PMI&#039;s smoke-free value proposition.
 </section>

 <section data-block="market-moving">
 <h3>Market-Moving</h3>
 <ul><li>BrandZ ranking boost could elevate investor sentiment on PMI&#039;s smoke-free strategy.</li><li>43% of Q1 2026 net revenues from smoke-free segment signals durable growth.</li><li>FDA MRTP approvals for IQOS-related products may support expanded commercial opportunities.</li></ul>
 </section>

 <section data-block="key-facts">
 <h3>Key Facts</h3>
 <ul><li>IQOS ranked #74 in BrandZ 2026 Top 100 global brands.</li><li>35+ million IQOS users worldwide.</li><li>PMI&#039;s smoke-free business ~43% of Q1 2026 total net revenues.</li><li>2025 smoke-free net revenues near $17 billion.</li><li>FDA authorized MRTP for IQOS devices and ZYN/general snus; reinforces growth trajectory.</li></ul>
 </section>

 <section data-block="trading-thesis">
 <h3>Trading Thesis</h3>
 BrandZ recognition reinforces PMI&#039;s long-term smoke-free growth; enter PM on pullbacks for multi-quarter upside.
 </section>
</section>



Recognition reinforces the growing consumer relevance of IQOS and the strength of Philip Morris International's smoke-free vision


Philip Morris International's (PMI) (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/PM">PM</a>) IQOS, the #1 tobacco heating system1, has been listed for the first time as one of the top 100 most valuable brands in the world in <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://www.kantar.com/" shape="rect">Kantar's</a> BrandZ 2026 Most Valuable Global Brands. This ranking solidifies IQOS's global momentum and its emergence as a culturally relevant, iconic brand for adult nicotine users seeking better alternatives to cigarettes.


According to the BrandZ 2026 Most Valuable Global Brands, IQOS achieved a ranking of #74 globally.


With more than 35 million IQOS users worldwide—most of whom have fully switched away from cigarettes2—the brand continues to lead from the front and champion in a smoke-free era through science-backed innovation and consumer-centric design. Within 10 years of inception, IQOS surpassed $10 billion in annual net revenues, reaching this milestone faster than some of the world's most recognized technology companies—and making up the large majority of Philip Morris International's smoke-free business which reached close to $17 billion in net revenues in 2025.


"This milestone is a powerful validation of the journey we are on," said Oggie Kapetanovic, President Heat-Not-Burn Products at Philip Morris International. "IQOS is not only the world's leading smoke-free brand - it is becoming a truly iconic brand, built on science, innovation, and consumer trust. This recognition reaffirms IQOS's continued growth and its pivotal role in transforming the industry. It inspires us to go further, faster, in delivering better alternatives for adults who would otherwise smoke."


BrandZ charts the way in which global brands have continued to evolve and innovate. Now in its 21st edition, it spotlights the importance of building meaningful difference where a brand meets consumer needs, stands out from competitors and remains top-of-mind in its sector for a prolonged period.


"The brand era has changed. People now interact with brands in thousands of different ways. Many of these are shaped by AI, like personalized feeds or LLMs that influence what we see. Machines are increasingly surfacing and prioritizing content. That means brands need to work harder than ever to stand out as meaningful and different," said Martin Guerrieria, Head of Kantar BrandZ.


IQOS's inclusion in the Kantar Top 100 for the first time underscores its growing role beyond product innovation — positioning the brand at the intersection of technology, design, and culture, aiming to meet the preferences of adult nicotine users. This recognition marks another important step toward achieving a future where cigarettes can become obsolete.


Other notable brands featured in this year's BrandZ 2026 global rankings include Google, Claude and Chinese-based companies like Alibaba and Xiaomi, highlighting industry leaders driving global brand value. Kantar BrandZ is a global ranking that assesses brand value by combining financial data and extensive brand equity research, offering an in-depth view of over 22,000 brands in 54 markets.


IQOS is not risk-free and provides nicotine, which is addictive. Only for use by adults who would otherwise smoke or use nicotine products.

<table xmlns="http://www.w3.org/1999/xhtml" cellspacing="0" class="bwtablemarginb bwblockalignl">
<tr xmlns="http://www.w3.org/1999/xhtml">
<td xmlns="http://www.w3.org/1999/xhtml" class="bwvertalignt bwpadl0" rowspan="1" colspan="1">
1 PMI global estimates of total in Market Sales of Heated Tobacco Units as of December 2025



</td>

</tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<td xmlns="http://www.w3.org/1999/xhtml" class="bwvertalignt bwpadl0" rowspan="1" colspan="1">
2 Source: PMI Q4 2025 Earnings Release



</td>

</tr>
</table>
Philip Morris International: A Global Smoke-Free Champion


Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 43% of PMI's first-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to "PMI", "we", "our" and "us" mean Philip Morris International Inc., and its subsidiaries. For more information, please visit <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.pmi.com/" shape="rect">www.pmi.com</a> and <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="http://www.pmiscience.com/" shape="rect">www.pmiscience.com</a>.


Forward-Looking and Cautionary Statements


This press release contains projections of future results and goals and other forward-looking statements, including statements regarding business plans and strategies. Achievement of future results is subject to risks, uncertainties, and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.


PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco and/or nicotine use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of natural disasters and pandemics on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products' performance.


PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2024 and the Quarterly Report on Form 10-Q for the second quarter ended June 30, 2025. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.


About Kantar


Kantar is the world's leading marketing data and analytics business. We deliver the intelligence needed to power brand growth.


We provide the signals that help organizations act quickly and confidently. We empower brands to make effective marketing decisions based on predictive evidence. And we help them craft powerful growth strategies rooted in the connection between consumers, brands and enterprise value. All this is powered by our uniquely robust human and synthetic data, our unrivalled IP, our AI-native platform and the team of global brand experts that bring this all together.


About Kantar BrandZ


Kantar BrandZ is the global currency when assessing brand value, quantifying the contribution of brands to business' financial performance. Kantar's annual global and local brand valuation rankings combine rigorously analyzed financial data, with extensive brand equity research. Since 1998, BrandZ has shared brand-building insights with business leaders based on interviews with 4.6 million consumers, for over 22,000 brands in 54 markets. Discover more about Kantar BrandZ <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://www.kantar.com/campaigns/brandz" shape="rect">here</a>.

<img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260526629537r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260526629537/en/" rel="nofollow">https://www.businesswire.com/news/home/20260526629537/en/</a>
Corey Henry
 Philip Morris International
 T: +1 (202) 679 7296
 E: <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:corey.henry@pmi.com" shape="rect">corey.henry@pmi.com</a>

Philip Morris International's IQOS has been recognized in BrandZ's 2026 Top 100 global brands, ranking #74 and underscoring strong momentum in smoke-free products. PMI notes over 35 million IQOS users and that the smoke-free segment comprised about 43% of Q1 2026 net revenues, with 2025 smoke-free net revenues near $17B. FDA MRTP approvals further validate the platform and could bolster growth and brand credibility.

IQOS One of the Most Valuable Global Brands, According to Kantar's BrandZ 2026 Ranking

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Industry News

Related News